← Open Payments lookup

PAMELA SUMMERS: Open Payments

NPI 1982240776 · ATHENS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,260 in 118 payments from 13 companies in 2025. Trend: 2023 $2,404 · 2024 $2,589 · 2025 $2,260

Food & beverage: $2,260
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.21$365
Vanda Pharmaceuticals Inc.14$353
Neurocrine BioSciences, Inc.13$333
ABBVIE INC.21$271
E.R. Squibb & Sons, L.L.C.15$244
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$198
Alkermes, Inc.11$180
Otsuka America Pharmaceutical, Inc.5$138
Lundbeck LLC3$73
Janssen Pharmaceuticals, Inc2$49

Products named: FANAPT, INGREZZA, UZEDY, VRAYLAR, COBENFY, CAPLYTA, ARISTADA, REXULTI.

Industry payments across TX — which companies pay providers there.